RGLS logo

Regulus Therapeutics (RGLS) Current Liabilities

Annual Current Liabilities

$8.51 M
-$3.15 M-27.01%

December 31, 2023


Summary


Performance

RGLS Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSbalance sheetmetrics:

Quarterly Current Liabilities

$6.48 M
+$1.22 M+23.16%

September 30, 2024


Summary


Performance

RGLS Quarterly Current Liabilities Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSbalance sheetmetrics:

Current Liabilities Formula

Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities

RGLS Current Liabilities Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-27.0%+23.2%
3 y3 years-26.5%+11.2%
5 y5 years-68.1%-69.1%

RGLS Current Liabilities Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-27.0%+62.8%-44.4%+37.9%
5 y5-year-60.6%+62.8%-70.0%+37.9%
alltimeall time-75.8%+62.8%-81.6%+37.9%

Regulus Therapeutics Current Liabilities History

DateAnnualQuarterly
Sep 2024
-
$6.48 M(+23.2%)
Jun 2024
-
$5.26 M(-7.4%)
Mar 2024
-
$5.68 M(-33.2%)
Dec 2023
$8.51 M(-27.0%)
$8.51 M(+3.2%)
Sep 2023
-
$8.25 M(+0.2%)
Jun 2023
-
$8.23 M(-6.7%)
Mar 2023
-
$8.82 M(-24.3%)
Dec 2022
$11.66 M(+123.0%)
$11.66 M(+10.8%)
Sep 2022
-
$10.52 M(+80.5%)
Jun 2022
-
$5.83 M(+24.0%)
Mar 2022
-
$4.70 M(-10.1%)
Dec 2021
$5.23 M(-54.9%)
$5.23 M(-54.4%)
Sep 2021
-
$11.46 M(+15.0%)
Jun 2021
-
$9.97 M(+1.1%)
Mar 2021
-
$9.86 M(-14.8%)
Dec 2020
$11.58 M(-46.4%)
$11.58 M(-40.6%)
Sep 2020
-
$19.48 M(-7.2%)
Jun 2020
-
$20.98 M(+6.0%)
Mar 2020
-
$19.79 M(-8.4%)
Dec 2019
$21.60 M(-18.9%)
$21.60 M(+2.8%)
Sep 2019
-
$21.00 M(+2.5%)
Jun 2019
-
$20.49 M(-17.5%)
Mar 2019
-
$24.84 M(-6.8%)
Dec 2018
$26.65 M
$26.65 M(+3.9%)
Sep 2018
-
$25.65 M(-16.7%)
DateAnnualQuarterly
Jun 2018
-
$30.80 M(-0.4%)
Mar 2018
-
$30.93 M(-5.1%)
Dec 2017
$32.60 M(+136.1%)
$32.60 M(+177.3%)
Sep 2017
-
$11.76 M(+5.7%)
Jun 2017
-
$11.12 M(+5.2%)
Mar 2017
-
$10.58 M(-23.4%)
Dec 2016
$13.81 M(+9.3%)
$13.81 M(+5.0%)
Sep 2016
-
$13.15 M(+18.5%)
Jun 2016
-
$11.10 M(+0.8%)
Mar 2016
-
$11.01 M(-12.8%)
Dec 2015
$12.63 M(-64.1%)
$12.63 M(-14.7%)
Sep 2015
-
$14.81 M(+1.8%)
Jun 2015
-
$14.55 M(+1.4%)
Mar 2015
-
$14.35 M(-59.2%)
Dec 2014
$35.19 M(+239.4%)
$35.19 M(+195.9%)
Sep 2014
-
$11.89 M(+5.6%)
Jun 2014
-
$11.27 M(+17.8%)
Mar 2014
-
$9.57 M(-7.7%)
Dec 2013
$10.37 M(-18.8%)
$10.37 M(-23.3%)
Sep 2013
-
$13.53 M(-28.8%)
Jun 2013
-
$19.00 M(+49.7%)
Mar 2013
-
$12.69 M(-0.6%)
Dec 2012
$12.77 M(-0.6%)
$12.77 M(-4.8%)
Sep 2012
-
$13.41 M(-20.2%)
Jun 2012
-
$16.80 M(+30.7%)
Dec 2011
$12.85 M
$12.85 M

FAQ

  • What is Regulus Therapeutics annual total current liabilities?
  • What is the all time high annual current liabilities for Regulus Therapeutics?
  • What is Regulus Therapeutics annual current liabilities year-on-year change?
  • What is Regulus Therapeutics quarterly total current liabilities?
  • What is the all time high quarterly current liabilities for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly current liabilities year-on-year change?

What is Regulus Therapeutics annual total current liabilities?

The current annual current liabilities of RGLS is $8.51 M

What is the all time high annual current liabilities for Regulus Therapeutics?

Regulus Therapeutics all-time high annual total current liabilities is $35.19 M

What is Regulus Therapeutics annual current liabilities year-on-year change?

Over the past year, RGLS annual total current liabilities has changed by -$3.15 M (-27.01%)

What is Regulus Therapeutics quarterly total current liabilities?

The current quarterly current liabilities of RGLS is $6.48 M

What is the all time high quarterly current liabilities for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly total current liabilities is $35.19 M

What is Regulus Therapeutics quarterly current liabilities year-on-year change?

Over the past year, RGLS quarterly total current liabilities has changed by +$1.22 M (+23.16%)